Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention
This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosis at twice the national average. Further, the declines are more than three times the national average decline in Kentucky's Central Appalachian region. Kentucky-based multilevel initiatives are needed to expand and accelerate this leading role and extend the LCS opportunity to more Kentuckians who are at increased risk of lung cancer. This trial may be able to accelerate optimal high-quality implementation of LCS utilizing the QUILS™ System and reduce the burden of lung cancer by assisting lung cancer screening programs located throughout Kentucky in implementing best practices in lung cancer screening by integrating the QUILS™ System domains and elements into their screening programs.
Checked against the public recordLast updated Jul 6, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Timothy Mullett
- Interventions being studied
- Behavioral: Quality Implementation of Lung Cancer Screening (QUILS) System
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Member of a participating Lung Cancer Screening Program (LCSP) team or administrator * Willing to participate in the QUILS Index Assessment Survey process * Willing to participate in the QUILS Audit Feedback presentations * Willing to participate in formative evaluation interviews Exclusion Criteria: * Unwilling to participate in the QUILS Index Assessment Survey process * Unwilling to participate in the QUILS Audit Feedback presentations * Unwilling to participate in formative evaluation interviews
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- King's Daughter's Medical CenterAshland, Kentucky
- Taylor Regional HospitalCampbellsville, Kentucky
- St. Elizabeth HealthcareEdgewood, Kentucky
- Georgetown Cancer Treatment CancerGeorgetown, Kentucky
- TJ Samson Community HospitalGlasgow, Kentucky
- Hazard Appalachian Regional Healthcare Medical CenterHazard, Kentucky
- Lexington VA Health Care SystemLexington, Kentucky
- St. Joseph Health (Catholic Health Initiatives)Lexington, Kentucky
- University of Kentucky Markey Cancer CenterLexington, Kentucky
- The James Graham Brown Cancer Center at University of LouisvilleLouisville, Kentucky
- Meadowview Regional Medical CenterMaysville, Kentucky
- Saint Claire Regional Medical CenterMorehead, Kentucky
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 6, 2026. Always confirm current availability with the study team.